The framework of pathology: good laboratory practice by quantitative and molecular methods

Combined confocal laser scan microscopy (CLSM) and Fourier analysis (FA) by non‐pathologists of dermal collagen bundle orientation recently gave results superior to subjective evaluation by experts. According to Good Laboratory Practice (GLP) criteria, combined CLSM/FA has not yet been adequately tested to replace current collagen evaluation, but this will not take long. Non‐pathologists (clinicians) will then have taken over a laboratory test historically belonging to pathology. A general trend in this direction may develop, because pathologists seem not always to care enough about clinical significance, reproducibility and prognostic value, and new demands for innovative methods. Quantitative image analysis (QIA) and molecular methods are reproducible, inexpensive, and easy to perform; they often have greater value than classical evaluations and their cost–benefit ratio is good. However, their acceptance is not as widespread as one would expect and theoretical reasons which have been advanced do not provide a satisfactory explanation. A formal implementation study was therefore performed, in which an attempt was made to modernize a classical pathology laboratory. An external customer satisfaction investigation showed that 96% of the clinicians were ‘very satisfied’ (the highest rating possible) with the completed innovations, contrasting with low satisfaction at the beginning. Lack of primary innovative leadership among pathologists was judged to be the dominant cause preventing implementation. Pathologists should focus on carefully reacting to new clinical needs, using GLP criteria. Reproducibility and predictive accuracy should be major themes in any pathology practice. Copyright © 2002 John Wiley & Sons, Ltd.

[1]  F T Bosman,et al.  Dysplasia classification: pathology in disgrace? , 2001, The Journal of pathology.

[2]  J. V. van Lanschot,et al.  Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation , 1998, The Journal of pathology.

[3]  A. Gad,et al.  Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. , 1998, Human pathology.

[4]  P. V. van Diest,et al.  Prospective Multicenter Evaluation of the Morphometric D-Score for Prediction of the Outcome of Endometrial Hyperplasias , 2001, The American journal of surgical pathology.

[5]  V. Abeler,et al.  DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary , 1993, International Journal of Gynecologic Cancer.

[6]  J. Bos,et al.  Dermal Organization in Scleroderma: The Fast Fourier Transform and the Laser Scatter Method Objectify Fibrosis in Nonlesional as well as Lesional Skin , 2000, Laboratory Investigation.

[7]  G. Haroske,et al.  Fourth Updated ESACP Consensus Report on Diagnostic DNA Image Cytometry , 2001, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[8]  J. Naeyaert,et al.  Inter‐observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions , 2002, The Journal of pathology.

[9]  J. Risteli,et al.  Metabolism of the aminoterminal propeptide of type III procollagen in cultures of human proximal tubular cells. , 1992, Scandinavian Journal of Clinical and Laboratory Investigation.

[10]  C H de Verdier,et al.  A quality manual for the clinical laboratory including the elements of a quality system. Proposed guidelines. , 1993, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[11]  F. A. Langley,et al.  Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing. , 1986, Analytical and quantitative cytology and histology.

[12]  R M Richart,et al.  Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry , 2000, The Journal of pathology.

[13]  J. V. van Sandick,et al.  Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus , 2000, The Journal of pathology.

[14]  E. Montgomery,et al.  Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. , 2001, Human pathology.

[15]  N. Nanninga,et al.  Three‐Dimensional Imaging by Confocal Scanning Fluorescence Microscopy a , 1986, Annals of the New York Academy of Sciences.

[16]  J. Sudbø Pathology in disgrace? , 2002, The Journal of pathology.

[17]  G. Sauter,et al.  Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer , 2000, BJU international.

[18]  P. V. van Diest,et al.  THREE‐DIMENSIONAL CONFOCAL LASER SCANNING DNA PLOIDY CYTOMETRY IN THICK HISTOLOGICAL SECTIONS , 1996, The Journal of pathology.

[19]  S. Chaudhuri,et al.  A Fourier Domain Directional Filterng Method for Analysis of Collagen Alignment in Ligaments , 1987, IEEE Transactions on Biomedical Engineering.

[20]  S J Schnitt,et al.  Interobserver Reproducibility in the Diagnosis of Ductal Proliferative Breast Lesions Using Standardized Criteria , 1992, The American journal of surgical pathology.

[21]  A. Talerman,et al.  The prognostic variability of ovarian tumor grading by different pathologists. , 1987, Gynecologic oncology.

[22]  K. Hahn,et al.  Evaluation of gastric motility by Fourier analysis of condensed images , 2000, European Journal of Nuclear Medicine.

[23]  V. Zaleckas,et al.  Laser scanning microscopy , 1982, Proceedings of the IEEE.

[24]  J. Sudbø,et al.  DNA content as a prognostic marker in patients with oral leukoplakia. , 2001, The New England journal of medicine.

[25]  J A Beliën,et al.  Measurement by confocal laser scanning microscopy of the volume of epidermal nuclei in thick skin sections. , 1994, Analytical and quantitative cytology and histology.

[26]  D. Genest Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[27]  B. Leyland-Jones Trastuzumab: hopes and realities. , 2002, The Lancet. Oncology.

[28]  Jan van Marle,et al.  Morphometry of dermal collagen orientation by Fourier analysis is superior to multi‐observer assessment , 2002, The Journal of pathology.